Historical review from 2026-10-30. Current price and availability are unconfirmed; check the original marketplace.
ScripTrade AI converts plain-language trading strategies into MQL4/5 Expert Advisors for MetaTrader, addressing a genuine pain point for non-technical traders. At $536.50/mo revenue and $429/mo profit, margins are strong at ~80%, and the 2.33x annual profit multiple is well below typical SaaS market rates. The business is only 3 months old, however, which means the revenue track record is limited and retention patterns are not yet established. Platform verification is a positive signal, though the youth of the business warrants additional diligence on customer cohorts and churn.
The core software — a prompt-to-MQL4/5 code generator using an LLM API — is reproducible by a capable solo founder in roughly 3-6 weeks using AI coding tools and an OpenAI or similar API subscription, at an estimated out-of-pocket cost of $800–$2,500. However, the verified revenue, existing customer base, and platform distribution provide meaningful traction that would take additional time to acquire organically. At $12,000, the asking price is modest and the buy verdict holds narrowly, though the 3-month age means limited retention evidence. Buyers comfortable with early-stage risk gain a head start on distribution; those preferring proven retention may find the build path competitive at this price point.
Cash estimate includes the AI tools, APIs and infrastructure needed for a solo founder to recreate the software. Build time is informational and lightly weighted. The verdict is driven mainly by customers, users, verified earnings, retention, distribution, brand, data and operating history.
Turns a plain-language trading strategy into a compiled, checked MQL4/5 Expert Advisor for MetaTrader 4/5, in minutes and without coding. Problem solved: Traders who want to automate a strategy either
Opens the original listing on TrustMRR
Get new listings with asking prices, monthly profit, deal scores, and key risks.
The best reviewed deals, concise and evidence-first. Unsubscribe anytime.
Preliminary screening based on marketplace and public data. Verify all financial, legal, technical, customer, and operational claims independently before making an acquisition decision. This is not financial or legal advice.